Active substances
Dextran 40 + Sodium chloride
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DEXTRAN-40 IN N.SALINE | 10,0.9 %,% | Solution · Intravenous use | 1 Bottle | SAR 24.95 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| DEXTRAN-40 IN N.SALINE | 10,0.9 % (W/V),% (W/V) | Solution · Intravenous use | 1 Bottle | SAR 27.10 | NCE · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| RHEOMACRODEX 10% IN SALINE OR DEXTROSE | Injection · Intravenous use | 1 Bottle | SAR 37.25 | Generic · Prescription | Advanced Medical Optics, Inc. (AMO) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
FLUIDS AND VOLUME EXPANDERS-MAINTENANCE FLUIDS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.